EcoDrugPlus

Caspase 9, Apoptosis-Related Cysteine Peptidase

Ensembl ID : ENSLCRG00005021138
Gene Symbol: CASP9
3 Cross references
202 Possible Orthologues:

Catechol O-Methyltransferase

Ensembl ID : ENSLCRG00005015287
Gene Symbol: LOC104919411
2 Cross references
177 Possible Orthologues:

Catechol-O-Methyltransferase B

Ensembl ID : ENSLCRG00005023001
Gene Symbol: COMTB
3 Cross references
215 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSLCRG00005004011
Gene Symbol: CTSC
3 Cross references
237 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSLCRG00005002683
Gene Symbol: CTSK
3 Cross references
222 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSLCRG00005006917
Gene Symbol: CTSS
3 Cross references
183 Possible Orthologues:

Cathepsin S, Ortholog2, Tandem Duplicate 1

Ensembl ID : ENSLCRG00005002696
Gene Symbol: CTSS2.1
3 Cross references
233 Possible Orthologues:

Cell Division Cycle 7 Homolog (S. Cerevisiae)

Ensembl ID : ENSLCRG00005004852
Gene Symbol: CDC7
3 Cross references
207 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSLCRG00005006562
Gene Symbol: CHEK1
3 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSLCRG00005007337
Gene Symbol: CHEK2
3 Cross references
205 Possible Orthologues:

Chemokine (C-C Motif) Receptor 9a

Ensembl ID : ENSLCRG00005002580
Gene Symbol: CCR9A
2 Cross references
188 Possible Orthologues:

Chemokine (C-C Motif) Receptor 9b

Ensembl ID : ENSLCRG00005013364
Gene Symbol: CCR9B
2 Cross references
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).